LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

LifeVantage Corporation hosted its annual ... study highlighting the synergistic benefits between this system and the Protandim® Nrf2 Synergizer. LifeVantage also introduced updated incentive ...

We are thrilled to welcome Todd to the LifeVantage team,” said Steve Fife, President and CEO of LifeVantage. “Todd’s exceptional track record in technology leadership and his forward-thinking approach ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company currently valued at $282 million with impressive gross profit margins of 79%, released a study today showing the ...

SALT LAKE CITY - LifeVantage (NASDAQ ... which includes the MindBody GLP-1 System™ and Protandim® Nrf2 Synergizer®. The study highlighted that the combination of these products activated ...

SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq ... third-party cell study on the synergistic impact of Protandim® Nrf2 Synergizer® and the MindBody GLP ...